This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Today's Small-Cap Winners and Losers

Spherix (SPEX - Get Report) surged 54% after the company said an agreement for a multinational late-stage clinical trial of its Naturlose as a type 2 diabetes drug is being completed.

Preliminary work is under way, and patient recruitment is expected to begin before the end of the year. Spherix has a unit that provides contact center information and reservations services and another involved in product development in the health, medicine and environmental fields. Shares of Spherix were up $1.12 to $3.20.

Scolr Pharma (DDD - Get Report) was dropping after the company released its financial results for fiscal 2005. Scolr lost $8.9 million, or 26 cents a share, last year, compared with a restated loss of $5.7 million and 19 cents a share for fiscal 2004.

Royalties from its dietary supplement products for 2005 totaled $635,407, an increase of 44% from the previous year. Shares of Scolr were losing 62 cents, or 9.8%, to $5.68.

RightNow Technologies (RNOW) jumped after the software company was upgraded by First Albany to strong buy from buy. Separately, the company announced that it had signed its 100th higher-education customer, Australia's Edith Cowan University. Shares gained $1.69, or 11.3%, to $16.62.

ICT Group (ICTG) stumbled after the customer-management software concern said it filed regulatory documents for a proposed public offering of 3 million shares.

The company said it will sell 2 million shares and stockholders will sell 1 million shares. Underwriters have the option to buy an additional 440,000 shares to cover overallotments. Shares of ICT were sinking $3.10, or 11.6%, to $23.60.

Harmonic (HLIT - Get Report) caught a bid following word that the digital-video systems company was upgraded by Kaufman Bros. to buy from hold. Shares gained 45 cents, or 7.5%, to $6.44. ChemGenex Pharmaceuticals (CXSP) was climbing after the company announced the publication of preclinical research supporting the expansion of its development of Ceflatonin to include the treatment of acute myeloid leukemia patients in addition to those with chronic myeloid leukemia and myelodysplastic syndrome.
1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
ICTG $26.00 0.00%
DDD $9.01 0.00%
FSI $0.82 0.00%
HLIT $5.59 0.00%
SPEX $0.24 0.00%


Chart of I:DJI
DOW 17,798.49 -14.90 -0.08%
S&P 500 2,090.11 +1.24 0.06%
NASDAQ 5,127.5250 +11.3820 0.22%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs